Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Veterinary use
Medicines
Current Page:Medicines

Medicines

Scientific-Technical Advice
Research & Development
- Clinical trials
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & delivery
Authorisation - Certificates
Declarations
- Medicines for export
Proper use

Last updated on 16/12/2020

Search information on an authorised medicine

(leaflet, SPC, RMA, DHPC, s-RMP)

Database of suspended medicines

human use
veterinary use

Search information on the availability of a medicine

General information

Search a medicine

Notification of adverse reactions or incidents

News

29/11/2023

Flash VIG-news: New measures to limit the risks of opioid abuse and dependence

06/11/2023

Medsafetyweek 2023: contribute to medicinal product safety

13/11/2023

PRAC November 2023 – Conclusion regarding available evidence not supporting link between the glucagon-like peptide-1 (GLP-1) receptor agonists and thyroid cancer

26/10/2023

Limited availability of GLP-1 analogues: recommendations for medical doctors (specialists), (hospital) pharmacists and patients

© 2016 - FAMHP

Sparsentan
Kaftrio
Rinvoq
Rinvoq
Privacy
Disclaimer

instructions how to enable JavaScript in your web browser